ISSUE:

The ISPOR Patient-Centered SIG aims to facilitate engagement and partnership of patients in all stages of health-related research and care delivery. Economic evaluation of health technologies is an important aspect in determining patient access to new technologies. Cost-effectiveness analyses (CEAs) are used in several countries to support coverage decision-making. To enhance inclusion of patient perspectives, preferences, and values, it is imperative to engage patients when designing CEAs and healthcare decision-making. However, there is a lack of guidance available on the appropriate approach to engaging patients in health economic research, which may be attributed to the inherent complexity of cost-effectiveness analyses. To address these concerns, the panel discussion organized by the SIG invites panelists to offer their insights on patient engagement in the economic evaluation of health technologies from HTA, economic modeling, and patient perspectives.

OVERVIEW:

Nan Qiao will give an overview of the background information, highlighting that despite the EU JCA implementation, many member states still conduct economic assessments to inform coverage and pricing decisions. Patient engagement in the economic assessment improves the patient-relevance of value assessment. However, determining the most appropriate approaches for patient engagement is essential given the complexity of economic assessment. Anke Peggy Holtorf will outline the broader values and possible methods of involving patients in HTA or the economic assessment as an HTA expert. Andrew Briggs will provide his insights from the perspective of a modeling expert, discussing the best approaches to engage patients in the design, implementation, and dissemination of cost-effectiveness analyses. Bettina Ryll will contribute insights from the patient perspective, emphasizing the value of patient engagement in the economic assessment and addressing the opportunities and challenges associated with patient engagement. The panel will be open for audience questions and suggestions to explore strategies for enhancing the relevance of health economic analysis from the patient perspective.